Ftse Mib
34.510,18
0,12%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
68.879,01
1,41%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sirna Therapeutics (RNAI) Sirna Therapeutics (RNAI) Notizie

RNAI

Sirna Therapeutics (RNAI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RNAI
DataOraFonteTitoloSimboloCompagnia
03/01/200814:00MarketwiredBoston-Power(R) Fuels Next Stage of Growth With One of the Largest Portable Power Venture InvestmentsNASDAQ:RNAISirna Therapeutics
28/12/200621:00PR Newswire (US)Sirna Therapeutics Shareholders Approve Acquisition by Merck & Co.NASDAQ:RNAISirna Therapeutics
14/12/200614:38Business WireMerck & Co. and Sirna Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period for the Proposed Acquisition of SirnaNASDAQ:RNAISirna Therapeutics
13/11/200622:36PR Newswire (US)Sirna Therapeutics Reports Third Quarter 2006 Financial ResultsNASDAQ:RNAISirna Therapeutics
30/10/200622:35Business WireMerck & Co., Inc. to Acquire Sirna Therapeutics, Inc.NASDAQ:RNAISirna Therapeutics
11/10/200616:00PR Newswire (US)Sirna Therapeutics to Present at 2006 BIO InvestorForumNASDAQ:RNAISirna Therapeutics
18/09/200621:19PR Newswire (US)Sirna Therapeutics to Present at UBS Global Life Sciences ConferenceNASDAQ:RNAISirna Therapeutics
08/09/200622:00PR Newswire (US)Sirna Therapeutics to Present at BioJapan 2006 World Business ForumNASDAQ:RNAISirna Therapeutics
31/08/200623:30PR Newswire (US)Sirna Therapeutics to Present at Two Upcoming ConferencesNASDAQ:RNAISirna Therapeutics
14/08/200623:04PR Newswire (US)Sirna Therapeutics Reports Second Quarter 2006 Financial ResultsNASDAQ:RNAISirna Therapeutics
10/08/200615:19PR Newswire (US)Sirna Therapeutics Reports Final Results from Phase 1 Study on Its RNAi-Based Therapeutic for Age-Related Macular DegenerationNASDAQ:RNAISirna Therapeutics
08/08/200600:25PR Newswire (US)Sirna Therapeutics to Report Second Quarter 2006 Financial Results on August 14, 2006NASDAQ:RNAISirna Therapeutics
03/08/200615:07PR Newswire (US)Sirna Therapeutics to Present at Bank of America 2006 Specialty Pharmaceuticals ConferenceNASDAQ:RNAISirna Therapeutics
06/07/200615:11PR Newswire (US)Sirna Therapeutics Joins Russell 3000 IndexNASDAQ:RNAISirna Therapeutics
05/07/200615:11PR Newswire (US)Sirna Therapeutics to Present at the C.E. Unterberg, Towbin Emerging Growth ConferenceNASDAQ:RNAISirna Therapeutics
23/06/200615:26PR Newswire (US)European Patent Office Significantly Limits Scope of Kreutzer-Limmer RNAi Patent ClaimNASDAQ:RNAISirna Therapeutics
08/06/200615:00PR Newswire (US)Sirna Therapeutics to Webcast Presentation at the Needham & Company Biotechnology and Medical Technology ConferenceNASDAQ:RNAISirna Therapeutics
30/05/200614:03PR Newswire (US)Sirna Therapeutics Announces Exercise of Over-Allotment Option By UnderwritersNASDAQ:RNAISirna Therapeutics
24/05/200613:14PR Newswire (US)Sirna Therapeutics Announces Pricing of Common Stock OfferingNASDAQ:RNAISirna Therapeutics
15/05/200613:13PR Newswire (US)Sirna Therapeutics Announces Public Offering of Common StockNASDAQ:RNAISirna Therapeutics
10/05/200615:20PR Newswire (US)Sirna Therapeutics Licenses Worldwide Exclusive Rights to microRNA Technology from University of Massachusetts Medical SchoolNASDAQ:RNAISirna Therapeutics
04/05/200614:36PR Newswire (US)Sirna Therapeutics Announces Programs in Strategic Research Alliance With GlaxoSmithKlineNASDAQ:RNAISirna Therapeutics
02/05/200614:36PR Newswire (US)Sirna Therapeutics Reports First Quarter 2006 Financial ResultsNASDAQ:RNAISirna Therapeutics
26/04/200614:08PR Newswire (US)Sirna Therapeutics to Report First Quarter 2006 Financial Results on May 2, 2006NASDAQ:RNAISirna Therapeutics
20/04/200614:02PR Newswire (US)Sirna Therapeutics to Webcast Presentation at the UBS Global Specialty Pharmaceuticals ConferenceNASDAQ:RNAISirna Therapeutics
03/04/200615:38PR Newswire (US)Sirna Therapeutics Granted First Broad siRNA Patent for a Gene Target in the United StatesNASDAQ:RNAISirna Therapeutics
03/04/200615:32PR Newswire (US)GlaxoSmithKline and Sirna Therapeutics Announce Major Alliance in RNAi-Based Therapeutics for Respiratory DiseaseNASDAQ:RNAISirna Therapeutics
29/03/200602:45PR Newswire (US)Sirna Therapeutics to Webcast Presentation at the CIBC World Markets Biotechnology & Specialty Pharmaceuticals ConferenceNASDAQ:RNAISirna Therapeutics
14/03/200614:37PR Newswire (US)Sirna Therapeutics Announces Its Scientific Advisory BoardNASDAQ:RNAISirna Therapeutics
01/03/200622:01PR Newswire (US)Sirna Therapeutics Reports Fourth Quarter and Year End 2005 Financial ResultsNASDAQ:RNAISirna Therapeutics
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RNAI

La tua Cronologia

NASDAQ
ABAAWXX
Bank of Montreal Dual Di...
USOTC
VHAQW
Viveon Health Acquisition (CE)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network